According to GSK, the non-name brand medications come in the same style ... "It's important to keep in mind that the list ...

Instead, pharmaceutical company GSK is manufacturing an authorized ... Insurance companies have a list of preferred ...

President Joe Biden’s career-defining victories over Big Pharma — reforming Medicare to lower prices and capping inhaler costs for millions of Americans with lung disease — are facing an ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

The main patent on Advair (fluticasone+salmeterol) expired as long ago as 2010, while the patent on GSK’s Diskus inhaler expired ... a significantly discounted list price, we will demonstrate ...

GSK acquired an experimental therapy from Chimagen Biosciences, paying $300 million upfront for the “T-cell engager” therapy, ...

However, early versions of fatty spheres for mRNA delivery won’t work for inhalable medications because the nanoparticles ...

Those using a rescue inhaler during an asthma attack, especially, may want a propellant to help push the medicine into their airways. This is why GSK Plc is focusing on lowering the emissions of ...

Medscape Medical News, October 04, 2024 Alert FDA Approves Dupilumab as Add-On for COPD Injectable biologic was approved as adjuvant therapy to inhaled medications ... 2024 GSK's Asthma Drug ...

GlaxoSmithKline Pharmaceuticals Ltd on Friday reported a 37.87 per cent rise in consolidated net profit at Rs 182.33 crore in the first quarter ended June 30, 2024. The company had posted a ...

Early fall is when asthma flare-ups peak in the U.S., and a warming climate is bad news for sufferers: It means more ground-level ozone, a longer pollen season and more wildfire smoke — all ...